Turn Therapeutics Inc. 8-K

What Happened
Turn Therapeutics Inc. announced on January 12, 2026 that it furnished a press release to the SEC via Form 8-K under Item 7.01 (Regulation FD Disclosure). The press release is included as Exhibit 99.1 to the filing.

Key Details

• Date filed: January 12, 2026.
• Filing item: Item 7.01 — Regulation FD Disclosure.
• Exhibit provided: Exhibit 99.1 — press release dated January 12, 2026.
• Technical exhibit: Exhibit 104 — Cover Page Interactive Data File (Inline XBRL).

Why It Matters
Furnishing a press release under Regulation FD means the company publicly disclosed information intended for broad investor access; the 8-K itself points investors to the full press release for details. The Form 8-K does not summarize the press release text, so investors should review Exhibit 99.1 (or the company's investor website) to see whether the release contains material news—such as financial results, clinical updates, corporate changes, or other items that could affect the stock.